Caribou Biosciences (CRBU)

• Market cap: $78.2M
• 1 day: -7.89%
• 5 days: -11.95%
• 1 month: -21.39%
• 3 months: -49.93%
• 6 months: -54.04%
• Year to date: -49.93%
• 1 year: -83.34%
• 5 years: -94.85%
• 10 years: -94.85%
• Sector: Healthcare
• Industry: Biological Products, Except Diagnostic Substances

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

74% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 27

36% more call options, than puts

Call options by funds: $240K | Put options by funds: $176K

23% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 22

5.91% more ownership

Funds ownership: 58.44% [Q3] → 64.35% (+5.91%) [Q4]

3% more funds holding

Funds holding: 128 [Q3] → 132 (+4) [Q4]

10% less capital invested

Capital invested by funds: $104M [Q3] → $93.1M (-$10.9M) [Q4]

50% less funds holding in top 10

Funds holding in top 10: 2 [Q3] → 1 (-1) [Q4]

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $9 970% upside
• Avg. target: $10 1,089% upside
• High target: $11 1,208% upside

2 analyst ratings

• positive: 2 100%
• neutral: 0 0%
• negative: 0 0%

HC Wainwright & Co. Robert Burns 18% 1-year accuracy 31 / 170 met price target	970% upside $9	Buy Reiterated	19 Mar 2025
B of A Securities Alec Stranahan 13% 1-year accuracy 1 / 8 met price target	1,208% upside $11	Buy Maintained	7 Jan 2025